Home > News > Invitrogen and Signalomics agree nanotechnology diagnostics deal
April 20th, 2006
Invitrogen and Signalomics agree nanotechnology diagnostics deal
Abstract:
Invitrogen and Signalomics have agreed terms to develop nanotechnology-based laboratory approaches to cancer diagnostics in a move that is set to make the identification of tumours easier and quicker. Signalomics has become prominent in the nanocrystal field, becoming one of the first to develop a nanobiotechnology-based in vivo diagnostics platform by coupling designer proteins with fluorescent semiconductor crystals. These nanocrystal-protein conjugates, which are only a few millionths of a millimetre in size and are extremely photostable, can be targeted to faulty signalling proteins that are expressed in tumour tissue.
Source:
outsourcing-pharma.com
Bookmark:
| Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||